Home LiteratureArticle Details
PMID: 13819370 Published · ppublish English Journal Article

Laboratory tests of typhoid vaccines used in a controlled field study.

Bulletin of the World Health Organization ·Vol. 20 ·1959-00-00 ·Pages 1017-32

EDSALL G, CARLSON MC, FORMAL SB, BENENSON AS

Abstract

In 1954-55, a controlled field trial of two types of typhoid vaccine-alcoholized ("vaccine A") and phenolized ("vaccine F")-prepared in Yugoslavia was carried out in the town and district of Osijek. In an attempt to correlate the protection conferred on man by these vaccines with their potency in laboratory animals, arrangements were made for laboratory tests to be performed jointly by the Central Institute of Hygiene, Zagreb, Yugoslavia; the Lister Institute of Preventive Medicine, Elstree, Herts, England; and the Walter Reed Army Institute of Research (WRAIR), Washington, D.C., USA. In this paper, the results of the WRAIR tests are presented.The potency relationship between vaccine A and vaccine F was found to vary with the type of test performed. According to active-immunization tests in mice, using either mucin or saline challenge, vaccine A was more potent than vaccine F, as it proved also in the passive immunization of mice with saline challenge and in Vi-antibody production in rabbits. As judged by the results of the passive immunization of mice with mucin challenge and of O-antibody production in rabbits, there was, however, no clear-cut difference in potency between the two vaccines. And, as indicated by H-antibody production in rabbits, vaccine F was clearly superior to vaccine A. Since vaccine F was also the more effective in man, the last-mentioned findings are of considerable interest, suggesting that the H antigen may be more, and the Vi antigen less, important in protecting man against typhoid fever than is currently considered to be the case.

Keywords
TYPHOID/immunology
MeSH Terms
Animals England Humans Male Mice Rabbits Typhoid Fever/immunology Typhoid-Paratyphoid Vaccines Vaccination Vaccines
Chemicals
Typhoid-Paratyphoid Vaccines Vaccines
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
EDSALL G
CARLSON M C
FORMAL S B
BENENSON A S
References (8)
8 references, click to expand
  1. Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.
    J Exp Med. 1956 Sep 1;104(3):383-409 PMID: 13357692
  2. Stimulation of natural immunity to Escherichia coli infection: observations on mice.
    Lancet. 1955 Jan 29;268(6857):232-4 PMID: 13234339
  3. Enhancement of the immunogenicity of typhoid vaccine by retention of the V1 antigen.
    Am J Hyg. 1953 Sep;58(2):148-64 PMID: 13080255
  4. Field trial of typhoid vaccines.
    Am J Public Health Nations Health. 1957 May;47(5):578-81 PMID: 13424806
  5. Antibody responses of man to three types of antityphoid immunizing agents: heat-phenol fluid vaccine, acetone-dehydrated vaccine, and isolated Vi and O antigens.
    Am J Public Health Nations Health. 1954 Dec;44(12):1572-9 PMID: 13207484
  6. Estimation of Vi antibody employing erythrocytes treated with purified Vi antigen.
    Proc Soc Exp Biol Med. 1953 Apr;82(4):593-8 PMID: 13055942
  7. Biological standardization of typhoid vaccines by antibody measurements.
    Acta Pathol Microbiol Scand. 1956;39(6):469-80 PMID: 13381494
  8. Second attacks of typhoid fever.
    J Hyg (Lond). 1953 Jun;51(2):260-7 PMID: 13069708
Article Info
Journal
Bulletin of the World Health Organization
Abbr.
Bull World Health Organ
ISSN
0042-9686
Published
1959-00-00
Pages
1017-32
Language
English
Region
Switzerland
NLM ID
7507052
PMCID
PMC2537884
Subset
OM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com